Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Inhaler Devices Market by Type (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Inhaler Devices Market by Type (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130350 3300 Medical Devices & Consumables 377 230 Pages 4.7 (31)

Market Overview:

The global inhaler devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in inhaler devices. Based on type, the global inhaler devices market is segmented into metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs). MDIs are further sub-segmented into pressurized metered dose inhalers (pMDIs) and non-pressurized metered dose inhalers (nMDIs). DPIs are further sub-segmented into single drug DPIS and combination drug DPIS. SMIs are further sub-segmented into ultrasonic nebulizers and vibrating mesh nebulizers. Based on application, the global market is segmented into adults and children. Adults are further divided into chronic obstructive pulmonary disease (COPD) patients, asthma patients, bronchitis patients, pneumonia patients, cystic fibrosis patients; while children are subdivided as those below 5 years of age and those aged between 5–18 years old. Geographically, the global market is segmentedinto North America,, Europe,, Asia Pacific,,and Middle East & Africa .

Global Inhaler Devices Industry Outlook

Product Definition:

An inhaler is a medical device that delivers medication to the lungs in the form of a mist, which is inhaled. Inhalers are used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.

Metered Dose Inhaler (MDI):

MDI is a device used to inhale drugs by the mouth. It's an alternative to traditional methods of drug delivery such as syringes and vials. MDI has been around for quite some time, but its growth factor in inhaler devices market was observed only recently due to increasing prevalence of chronic respiratory diseases such as asthma, COPD and Chronic Obstructive Pulmonary Disease (COPD).

Dry Powder Inhaler (DPI):

Dry powder inhaler (DPI) is a device used to deliver dry powder medication through an inhalation therapy. The most common type of dry powders are the nebulizers, which produce a mixture of gases such as oxygen and water vapor that are then inhaled by the patient. DPI’s work in much the same way as nebulizers; however, they do not require any liquid to be added along with it for its operation.

Application Insights:

The adults segment held the largest share of 60.0% in 2017 owing to the high usage of inhalers for asthma treatment among adults. Asthma is a chronic lung disease which affects approximately 40 million people in U.S., Canada and Europe, accounting for around 4% to 5% of total population.

Regional Analysis:

North America dominated the global market in 2017 owing to favorable reimbursement policies, high awareness levels about asthma management, and presence of major players. In addition, increasing prevalence of respiratory diseases is also expected to drive the demand for inhaler devices in this region. According to data published by CDC’s National Center for Health Statistics (NCHS), between 2010 and 2015 around 18% increase was observed in the number of adults with asthma. Moreover, an estimated 6 million children under 18 years had asthma in 2014 which is approximately 4% increase from 2011.

Asia Pacific is expected to witness lucrative growth over the forecast period due as a result of rising disposable income coupled with growing target population base especially among geriatric population group that requires long-term treatment for their chronic respiratory conditions such as COPD or asthma.

Growth Factors:

  • Increasing prevalence of respiratory diseases: The global inhaler devices market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis. Inhalers are used for the treatment of these diseases and help in relieving symptoms such as shortness of breath, chest tightness, wheezing, and coughing.
  • Technological advancements: The development of novel inhaler devices with advanced features is one of the key growth drivers for this market. These devices offer better patient compliance owing to their easy-to-use designs and enhanced performance characteristics such as dose delivery accuracy and reduced side effects.
  • Growing demand from emerging markets: The demand for inhaler devices is growing rapidly in emerging markets due to the increasing awareness about their benefits among patients and healthcare professionals alike. Additionally, rising income levels are enabling more people in these regions to afford expensive therapies that require use of inhalers Devices market . This is likely to result in significant growth opportunities for players operating in this market over the next few years..

Scope Of The Report

Report Attributes

Report Details

Report Title

Inhaler Devices Market Research Report

By Type

Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)

By Application

Adults, Children

By Companies

3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GSK, PARI Medical Holding, Teva Pharmaceutical Industries Ltd

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Inhaler Devices Market Report Segments:

The global Inhaler Devices market is segmented on the basis of:


Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Adults, Children

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. 3M
  2. Bespak
  3. Gerresheimer AG
  4. Hovione
  5. Iconovo AB
  6. Adherium
  7. Cohero Health
  8. Trudell Medical International
  9. Beximco Pharmaceuticals Ltd
  10. Boehringer Ingelheim GmbH
  11. Cipla Ltd
  12. GSK
  13. PARI Medical Holding
  14. Teva Pharmaceutical Industries Ltd

Global Inhaler Devices Market Overview

Highlights of The Inhaler Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Metered Dose Inhaler (MDI)
    2. Dry Powder Inhaler (DPI)
    3. Soft Mist Inhaler (SMI)
  1. By Application:

    1. Adults
    2. Children
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Inhaler Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Inhaler Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Inhaler devices are medical devices that help people breathe easier. They come in a variety of shapes and sizes, and can be used to treat a variety of conditions, such as asthma, COPD (chronic obstructive pulmonary disease), or allergies. Inhalers work by delivering an aerosolized medication directly into the lungs. This helps to open up the airways and improve breathing.

Some of the key players operating in the inhaler devices market are 3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GSK, PARI Medical Holding, Teva Pharmaceutical Industries Ltd.

The inhaler devices market is expected to register a CAGR of 6.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Inhaler Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Inhaler Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Inhaler Devices Market - Supply Chain
   4.5. Global Inhaler Devices Market Forecast
      4.5.1. Inhaler Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Inhaler Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Inhaler Devices Market Absolute $ Opportunity

5. Global Inhaler Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Inhaler Devices Market Size and Volume Forecast by Type
      5.3.1. Metered Dose Inhaler (MDI)
      5.3.2. Dry Powder Inhaler (DPI)
      5.3.3. Soft Mist Inhaler (SMI)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Inhaler Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Inhaler Devices Market Size and Volume Forecast by Application
      6.3.1. Adults
      6.3.2. Children
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Inhaler Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Inhaler Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Inhaler Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Inhaler Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Inhaler Devices Demand Share Forecast, 2019-2029

9. North America Inhaler Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Inhaler Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Inhaler Devices Market Size and Volume Forecast by Application
      9.4.1. Adults
      9.4.2. Children
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Inhaler Devices Market Size and Volume Forecast by Type
      9.7.1. Metered Dose Inhaler (MDI)
      9.7.2. Dry Powder Inhaler (DPI)
      9.7.3. Soft Mist Inhaler (SMI)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Inhaler Devices Demand Share Forecast, 2019-2029

10. Latin America Inhaler Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Inhaler Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Inhaler Devices Market Size and Volume Forecast by Application
      10.4.1. Adults
      10.4.2. Children
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Inhaler Devices Market Size and Volume Forecast by Type
      10.7.1. Metered Dose Inhaler (MDI)
      10.7.2. Dry Powder Inhaler (DPI)
      10.7.3. Soft Mist Inhaler (SMI)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Inhaler Devices Demand Share Forecast, 2019-2029

11. Europe Inhaler Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Inhaler Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Inhaler Devices Market Size and Volume Forecast by Application
      11.4.1. Adults
      11.4.2. Children
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Inhaler Devices Market Size and Volume Forecast by Type
      11.7.1. Metered Dose Inhaler (MDI)
      11.7.2. Dry Powder Inhaler (DPI)
      11.7.3. Soft Mist Inhaler (SMI)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Inhaler Devices Demand Share, 2019-2029

12. Asia Pacific Inhaler Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Application
      12.4.1. Adults
      12.4.2. Children
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Type
      12.7.1. Metered Dose Inhaler (MDI)
      12.7.2. Dry Powder Inhaler (DPI)
      12.7.3. Soft Mist Inhaler (SMI)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Inhaler Devices Demand Share, 2019-2029

13. Middle East & Africa Inhaler Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Application
      13.4.1. Adults
      13.4.2. Children
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Type
      13.7.1. Metered Dose Inhaler (MDI)
      13.7.2. Dry Powder Inhaler (DPI)
      13.7.3. Soft Mist Inhaler (SMI)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Inhaler Devices Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Inhaler Devices Market: Market Share Analysis
   14.2. Inhaler Devices Distributors and Customers
   14.3. Inhaler Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. 3M Overview Financials Developments Strategic Outlook
      14.4.2. Bespak Overview Financials Developments Strategic Outlook
      14.4.3. Gerresheimer AG Overview Financials Developments Strategic Outlook
      14.4.4. Hovione Overview Financials Developments Strategic Outlook
      14.4.5. Iconovo AB Overview Financials Developments Strategic Outlook
      14.4.6. Adherium Overview Financials Developments Strategic Outlook
      14.4.7. Cohero Health Overview Financials Developments Strategic Outlook
      14.4.8. Trudell Medical International Overview Financials Developments Strategic Outlook
      14.4.9. Beximco Pharmaceuticals Ltd Overview Financials Developments Strategic Outlook
      14.4.10. Boehringer Ingelheim GmbH Overview Financials Developments Strategic Outlook
      14.4.11. Cipla Ltd Overview Financials Developments Strategic Outlook
      14.4.12. GSK Overview Financials Developments Strategic Outlook
      14.4.13. PARI Medical Holding Overview Financials Developments Strategic Outlook
      14.4.14. Teva Pharmaceutical Industries Ltd Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us